What Are Stem Cells?A Complete Guide to Types & Characteristics (April 2026)

 

Regenerative Medicine Basics | Core Column

What Are Stem Cells?
A Complete Guide to Types & Characteristics (April 2026)

Why is PRP not a stem cell therapy? The real differences between BMAC and SVF, MSC content comparisons, and the regulatory landscape for cultured and allogeneic stem cells — a regenerative medicine physician writes with scientific evidence.

April 7, 2026 #StemCells #PRP #BMAC #SVF #RegenerativeMedicine #AdvancedTherapy

🩺 About Dr. Joo

Hello. I'm Dr. Joo, a regenerative medicine specialist dedicated to finding solutions for intractable diseases through stem cell therapy and regenerative medicine.
With 15 years of experience as a board-certified emergency medicine physician — working on the front lines of life and death — I now serve as the principal investigator at a Ministry of Health and Welfare-designated Advanced Regenerative Medicine institution in South Korea. This blog goes beyond basic procedure information; my goal is to share the scientific vision of regenerative medicine, grounded in clinical evidence.

Anti-Aging & Aesthetics

Stem cell anti-aging · Hair loss treatment · Facial skin booster · Fat grafting

Joint Regeneration

PRP · Bone marrow BMAC · Adipose SVF — intensive knee osteoarthritis treatment

Intractable Disease Research

Investigating fundamental treatment mechanisms using advanced regenerative medicine technologies

📋 Table of Contents

1. The Most-Asked AI Questions About Stem Cells
2. What Are Stem Cells? — Starting with the Basics
3. Types of Stem Cells: Classification by Source
4. PRP · BMAC · SVF Compared — MSC Content & Clinical Efficacy
5. Cultured & Allogeneic Stem Cells: Regulatory Landscape in Korea, Japan & the US
6. What's Possible Now — and What's Coming Next
7. How to Choose the Right Clinic and Physician

🤖 The Most-Asked AI Questions About Stem Cells

As of 2026, these are among the most common stem cell questions people ask AI assistants like ChatGPT or Gemini.

❓ "Is PRP a stem cell treatment?"

The most commonly misunderstood question. The short answer: No. We'll explain precisely why below.

❓ "Which is better — BMAC or SVF?"

It depends on the clinical objective. Rather than a simple ranking, we'll walk through the evidence for each.

❓ "What can stem cell injections actually improve?"

We'll cover both the proven benefits and the real limitations. Stem cells are not a cure-all.

❓ "Is stem cell treatment legal?"

The answer varies dramatically depending on whether cells are autologous, cultured, or allogeneic — and which country you're in.

📌 Why this article matters: The internet — and many clinic websites — are saturated with content marketing stem cells as a miracle cure. But accurate explanations of what stem cells actually are, what they can and can't do, and what's legally permitted are remarkably rare. This column is written to give anyone considering stem cell therapy a real, evidence-based framework for evaluating clinics and physicians.

🔬 What Are Stem Cells? — Starting with the Basics

Stem cells are defined by two extraordinary abilities. First, self-renewal — the capacity to produce identical copies of themselves indefinitely. Second, differentiation — the ability to transform into specialized functional cells such as bone cells, cartilage cells, muscle cells, or fat cells.

Think of stem cells as the body's raw material. Like a factory's base components, they become different parts depending on where they're directed. It's precisely this versatility that makes them the cornerstone of regenerative medicine.

💡 Why Stem Cells Have Captured Medicine's Attention

Conventional medicine suppresses symptoms or removes damaged tissue. Regenerative medicine aims to rebuild the damaged tissue itself. Knee osteoarthritis where cartilage has worn away, hair loss where follicles have been destroyed, damaged nerve tissue — conditions once considered permanent are now being approached from a fundamentally new direction.

🧬 Types of Stem Cells: Classification by Source

Type	Abbreviation	Source	Differentiation Potential	Clinical Use	Ethics & Regulation
Embryonic Stem Cells	ESC	Early embryo	Pluripotent (all cell types)	Research stage	Strictly restricted
Induced Pluripotent Stem Cells	iPSC	Reprogrammed somatic cells	Pluripotent	Clinical trials underway	Varies by country
Mesenchymal Stem Cells	MSC	Bone marrow, adipose tissue, cord blood	Multipotent (mesodermal lineage)	Most actively used today	Autologous: permitted
Hematopoietic Stem Cells	HSC	Bone marrow, cord blood	Blood cell lineage	Established (leukemia, etc.)	Well-regulated
Adipose-Derived Stem Cells	ADSC / SVF	Adipose tissue	Multipotent	Joints, aesthetics, immunity	Autologous: permitted

The cell type most widely used in regenerative medicine today is the Mesenchymal Stem Cell (MSC). MSCs can differentiate into bone, cartilage, muscle, and fat — and crucially, they possess powerful immunomodulatory and anti-inflammatory properties. The therapeutic value lies not just in generating new cells, but in calming the damaged biological environment around injured tissue.

Where Are MSCs Found? — Comparing Sources

MSCs exist throughout the body — in bone marrow, adipose tissue, cord blood, dental pulp, the placenta, and more. However, MSC concentration and characteristics vary significantly by source.

💉 PRP · BMAC · SVF Compared — Where Does Genuine Stem Cell Therapy Begin?

⚠️ A Critical Misconception to Address First: Many clinics market PRP as a "blood stem cell therapy." This is medically inaccurate. PRP is a platelet concentrate — it is not stem cell therapy.

① PRP (Platelet-Rich Plasma)

PRP is produced by centrifuging a patient's own blood to concentrate the platelets. The alpha granules within platelets contain a range of growth factors — PDGF, TGF-β, VEGF, IGF-1, and others — that promote tissue repair. PRP is widely used for joint pain, hair loss, and skin rejuvenation.

🔑 Key Point: PRP contains virtually no MSCs. The concentration of MSCs in peripheral blood is less than 0.001% of nucleated cells — clinically insignificant. Any clinic that markets PRP as a "blood stem cell therapy" is making a misleading claim.

② BMAC (Bone Marrow Aspirate Concentrate)

BMAC is produced by aspirating bone marrow from the iliac crest (the hip bone) and concentrating it through centrifugation. Bone marrow contains not only MSCs, but also hematopoietic stem cells, diverse growth factors, and cytokines — making it a biologically rich preparation.

While the MSC content in bone marrow is approximately 0.001–0.01% of nucleated cells, concentration significantly elevates the functional cell count compared to PRP. BMAC contains bone marrow-derived MSCs (BM-MSCs), which have demonstrated strong efficacy in cartilage regeneration.

🦴 Why BMAC Is Underutilized at Aesthetic Clinics

BMAC requires iliac crest aspiration — a procedure involving bone marrow collection that demands orthopedic technique and appropriate pain management. Clinics focused primarily on aesthetics often lack the infrastructure or training for this approach, which is why BMAC tends to be underperformed outside specialized settings. Yet for conditions such as rosacea, atopic dermatitis, and other autoimmune-related skin disorders, BMAC's immunomodulatory effects can be exceptional — and it remains significantly underappreciated in these areas.

③ SVF (Stromal Vascular Fraction)

SVF is obtained by harvesting a small volume of adipose (fat) tissue — typically from the abdomen — then enzymatically digesting and centrifuging it. SVF is not a single cell type but a complex cellular mixture: MSCs (ADSCs), endothelial cells, pericytes, T cells, and M2 macrophages all coexist within it.

The MSC fraction within SVF accounts for approximately 45% of nucleated cells — dramatically higher than what is found in bone marrow concentrate. Adipose tissue contains roughly 5,000 MSCs per gram, which is several hundred times more than an equivalent volume of bone marrow.

🌟 SVF's Dual Regenerative Effect: When performing SVF therapy, the harvested fat can be simultaneously refined for fat grafting. This means patients can benefit from both volume restoration through fat grafting and the cellular regenerative effects of SVF in a single session — a particularly compelling option for those seeking facial volume recovery combined with dermal regeneration

PRP · BMAC · SVF — Core Comparison

Category	PRP	BMAC	SVF
Harvest Site	Peripheral blood (venous)	Iliac crest (bone marrow)	Adipose tissue (abdomen, etc.)
MSC Content	Negligible (clinically insignificant)	0.001–0.01% of nucleated cells	~45% of nucleated cells
Key Components	Platelets, growth factors	MSC, hematopoietic stem cells, cytokines	MSC, endothelial cells, pericytes, M2 macrophages
Procedural Complexity	Low (simple blood draw)	High (bone marrow aspiration required)	Moderate–High (includes lipoaspiration)
Primary Indications	Joint pain relief, hair loss, skin rejuvenation	Joint cartilage regeneration, rosacea, autoimmune conditions	Joint regeneration, skin rejuvenation, immune modulation, combined fat grafting
Is It Stem Cell Therapy?	❌ No	✅ Yes	✅ Yes
Level of Evidence	Moderate (numerous meta-analyses)	Moderate–High (4-year follow-up data available)	Moderate (growing body of clinical research)
Legal Status (Korea)	Approved new medical technology (autologous)	Approved new medical technology (autologous)	Approved new medical technology (autologous)

📊 Clinical Evidence Summary — Which Treatment Performs Best?

A 2024 meta-analysis covering 15 studies and 585 patients found that bone marrow-derived MSC (BM-MSC) therapy was most effective for pain reduction (VAS scores) and improvement in range of motion (ROM). Adipose- and cord blood-derived MSCs showed stronger results on functional outcome scores (WOMAC). BMAC demonstrated significantly superior outcomes compared to hyaluronic acid (HA) and corticosteroids — with effects becoming statistically meaningful from the second year of follow-up onward.

⚖️ Cultured & Allogeneic Stem Cells: Regulatory Landscape in Korea, Japan & the US (2026)

PRP, BMAC, and SVF are all autologous therapies — meaning the patient's own cells are minimally processed and administered on the same day. The regulatory complexity intensifies significantly when cells are cultured (expanded in a lab) or derived from a donor (allogeneic).

The Four-Level Spectrum of Cell Therapy

• 1
  Concentrates (PRP, BMAC, SVF) Autologous, minimally manipulated, same-day — permitted as approved new medical technologies in most countries worldwide
• 2
  Cultured Autologous Stem Cells Patient's own cells expanded millions of times in a laboratory — Korea: requires research approval under the Advanced Regenerative Medicine Act / US: FDA IND application required / Japan: conditional early approval permitted under the Sakura Act
• 3
  Allogeneic Stem Cells Cells sourced from a donor — Korea: classified as a pharmaceutical product, product approval required / US: BLA approval / Japan: regenerative medicine product approval
• 4
  iPSC-Derived Cells Pluripotent stem cells produced by reprogramming somatic cells — clinical trials active worldwide; Japan is furthest ahead

Category	🇰🇷 South Korea	🇯🇵 Japan	🇺🇸 United States
Autologous concentrates (PRP · BMAC · SVF)	✅ Approved new medical technology	✅ Permitted	✅ Permitted (minimal manipulation standard)
Cultured autologous stem cells	Research approval required under the Advanced Regenerative Medicine Act	Conditional early approval possible under the Sakura Act	FDA IND application required for clinical trials
Allogeneic stem cells (donor-derived)	Product approval required as pharmaceutical (zero approvals since 2020)	Regenerative medicine product approval (actively supported)	BLA approval (50+ products in pipeline)
iPSC clinical trials	Limited research permitted	Global leader (Prof. Yamanaka's iPS Cell Research Foundation)	Actively progressing
Regulatory stance	Strict (paradoxically tightened after the Advanced Regenerative Biopharmaceutical Act)	Flexible (conditional early approval system)	Moderate (trial-friendly, strong safety oversight)

📌 The Regulatory Reality: South Korea was the first country in the world to commercialize a stem cell therapeutic — back in 2001. Yet since the Advanced Regenerative Biopharmaceutical Act came into force in 2020, not a single new product approval has been granted. Meanwhile, Japan has invested approximately 1 trillion yen (roughly USD 7 billion) in stem cell research over the past decade, emerging as a global leader. In a striking irony, an estimated 20,000 South Korean patients travel to Japan annually to receive stem cell treatments that are unavailable at home

🌱 What's Possible Now — and What's Coming Next

Clinically Demonstrated Applications

🦵

Knee Osteoarthritis

PRP, BMAC, and SVF all demonstrate superior pain reduction and functional improvement compared to hyaluronic acid and corticosteroids. BMAC shows sustained efficacy confirmed at 4-year follow-up.

💆

Hair Loss (AGA & Alopecia Areata)

PRP, BMAC, and SVF all show meaningful hair follicle regeneration effects. Clinical trials applying cultured ADSCs are actively underway.

🌸

Skin Regeneration & Anti-Aging

Combined SVF and fat grafting delivers dual regenerative effects: dermal repair, volume restoration, and skin tone improvement in a single session. Exosome-based therapies are also in active clinical development.

🔴

Rosacea & Autoimmune Skin Conditions

The immunomodulatory properties of BMAC and SVF are being applied to rosacea, atopic dermatitis, psoriasis, and other inflammatory skin conditions. The secretion of anti-inflammatory cytokines by MSCs is the central mechanism.

Future Therapies in Active Clinical Development

Clinical trials based on cultured stem cells and iPSC-derived cell products are advancing rapidly worldwide. Key research targets include Parkinson's disease, spinal cord injury, type 1 diabetes, heart failure, and ALS (Lou Gehrig's disease). In 2024, Japan reported motor function improvement in a Parkinson's patient following transplantation of iPSC-derived dopaminergic neurons — a landmark in the field.

📋 Global Clinical Trial Status (as of 2026)

As of 2026, more than 1,000 MSC-related clinical trials are registered on ClinicalTrials.gov. Musculoskeletal applications (joints, bone, tendons) account for approximately 22%, neurological conditions for about 18%, and cardiovascular applications for around 15%. The safety record continues to strengthen, though long-term efficacy data for many indications is still being established.

🏥 How to Choose the Right Clinic and Physician

When considering stem cell therapy, choosing the right clinic and physician is the single most important decision you'll make. In a landscape where much of the industry is driven by marketing, here are the concrete criteria to verify for yourself.

What to Check	Green Flags ✅	Red Flags ⚠️
Institutional credentials	Officially designated Advanced Regenerative Medicine institution (or equivalent national certification)	No credentials disclosed / unverifiable
Physician expertise	Board-certified specialist in a relevant field; demonstrated research background in stem cell therapy	No clear specialty; physician credentials undisclosed
Diagnostic process	Thorough pre-procedure evaluation — MRI, blood tests, and individualized assessment before any procedure is recommended	Procedure recommended immediately after a brief consultation
How outcomes are framed	Clearly explains both expected benefits and realistic limitations upfront	"Guaranteed improvement" / claims of a definitive cure
How PRP is described	"PRP is a platelet-based therapy — it is not a stem cell treatment."	"PRP is a blood stem cell therapy."
Use of evidence	Explains recommendations with reference to peer-reviewed research and clinical data	Relies solely on patient testimonials; no scientific references provided
Acknowledges limitations	"In your case, results may be limited — here's why." Recommends against a procedure when it's not appropriate.	Recommends the same treatment regardless of the patient's specific condition

⚠️ A word of caution: A clinic that markets PRP as "stem cell therapy" has already demonstrated that it cannot accurately convey the most fundamental concepts in this field. If the basics are wrong, it is reasonable to question the accuracy of everything else they tell you.

📚 References

1. Pabinger C, et al. "Intra-articular injection of bone marrow aspirate concentrate (mesenchymal stem cells) in KL grade III and IV knee osteoarthritis: 4 year results of 37 knees." Scientific Reports, 2024;14:2665.
2. Pabinger C, Kobinia GS, Dammerer D. "Injection therapy in knee osteoarthritis: cortisol, hyaluronic acid, PRP, or BMAC (mesenchymal stem cell therapy)?" Frontiers in Medicine, 2024;11:1463997.
3. Nguyen BNH, et al. "Hyaluronic acid, platelet-rich plasma, bone marrow aspirate concentrate, the stromal vascular fraction, or mesenchymal stem cells: which is the best candidate for treating knee osteoarthritis?" Biomedical Research and Therapy, 2023;10(12).
4. Gangadhar P, et al. "Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate." Bioengineering (MDPI), 2022;9(2):57.
5. Bourin P, et al. "Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)." Cytotherapy, 2013;15(6):641-648.
6. McIntosh KR, et al. "Adipose-Derived Stromal Vascular Fraction Cells: Update on Clinical Utility and Efficacy." Plastic and Reconstructive Surgery, 2021;147(6):1564-1578.
7. Comella K, et al. "First-in-man intravenous implantation of stromal vascular fraction in psoriasis: a case study." Journal of Translational Medicine, 2018;16:60.

🏁 Closing Thoughts — Regenerative Medicine: Between Hope and Realism

Stem cell therapy and regenerative medicine are genuinely opening new frontiers in modern medicine. But in the present moment, most stem cell treatments are better understood as regenerative support rather than a cure. Results vary meaningfully from patient to patient.

A good physician asks what the patient actually needs before recommending any procedure. They explain both the expected benefits and the real limitations. They know the precise difference between PRP and BMAC. And when a treatment isn't right for a patient's situation, they say so — clearly and honestly.

I hope this article gives you a stronger foundation for making informed decisions. I'll continue sharing the latest from the frontier of regenerative medicine, always grounded in scientific evidence.

📌 Learn More About Dr. Joo & Saeron Clinic

If you'd like to explore further or get in touch, visit the links below.

🩺 Dr. Joo's Medical Philosophy → 🏥 Saeron Clinic Official Website →

The information provided in this blog is for educational and informational purposes only. Individual treatment decisions should always be made in consultation with a qualified medical professional.